Dexcom (DXCM) 92.09 $DXCM DexCom Announces Upcoming

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dexcom (DXCM) 92.09 $DXCM

DexCom Announces Upcoming Conference Presentation
BusinessWire - Thu Sep 01, 3:30PM CDT
DexCom, Inc. (NASDAQXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
DXCM: 92.09 (+0.38)

New Wearable Devices in the Medical and Diagnostic Sectors
PR Newswire - Tue Aug 30, 8:00AM CDT
A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual's vital signs. According to a recent report by Researchmoz, the global diagnostic wearable medical devices market is set to grow at a CAGR of 14.01% during the period 2016-2020. Biotricity Inc. (OTCQB: BTCY), DexCom, Inc. (NASDAQ: DXCM), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL), Fitbit Inc. (NASDAQ: FIT).
FIT: 14.96 (+0.01), DXCM: 92.09 (+0.38), GOOGL: 796.87 (+5.47)

DexCom Up 36.4% Since SmarTrend Uptrend Call (DXCM)
Comtex SmarTrend(R) - Mon Aug 29, 1:08PM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQXCM) on June 3rd, 2016 at $67.24. In approximately 3 months, DexCom has returned 36.43% as of today's recent price of $91.74.
DXCM: 92.09 (+0.38)

Research Report Initiation on These Healthcare Stocks -- VWR Corp., DexCom, Laboratory Corp. of America, and PerkinElmer
PR Newswire - Thu Aug 25, 7:00AM CDT
Operators in the Medical Laboratories and Research segment provide healthcare practitioners with information concerning the onset, severity, and cause of patients' ailments and illnesses. Equities under evaluation on Stock-Callers.com are: VWR Corp. (NASDAQ: VWR), DexCom Inc. (NASDAQ: DXCM), Laboratory Corp. of America Holdings (NYSE: LH), and PerkinElmer Inc. (NYSE: PKI). Learn more about these stocks by downloading their free report at:
DXCM: 92.09 (+0.38), VWR: 27.79 (+0.04), LH: 137.71 (+1.58), PKI: 53.46 (+0.20)

DexCom Set to Possibly Pullback After Yesterday's Rally of 1.21%
Comtex SmarTrend(R) - Wed Aug 24, 1:33PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $91.63 to a high of $93.87. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $92.25 on volume of 438,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 92.09 (+0.38)

Shares of DXCM Up 34.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 19, 1:12PM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQXCM) on June 3rd, 2016 at $67.24. In approximately 3 months, DexCom has returned 34.27% as of today's recent price of $90.29.
DXCM: 92.09 (+0.38)

Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 4:34PM CDT
The MiniMed 630G basically combines SmartGuard technology which is already featured in the MiniMed 530G system with a brand new user-friendly design.
ABT: 42.09 (-0.21), BDX: 177.32 (+0.30), DXCM: 92.09 (+0.38), MDT: 87.32 (+0.34)

Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:15AM CDT
Medtronic plc's (MDT) MiniMed 630G system with SmartGuard technology recently won the U.S. FDA approval for its commercial launch.
ABT: 42.09 (-0.21), BDX: 177.32 (+0.30), DXCM: 92.09 (+0.38), MDT: 87.32 (+0.34)

Uptrend Call Working As DexCom Stock Rises 35.3% (DXCM)
Comtex SmarTrend(R) - Fri Aug 12, 12:41AM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQXCM) on June 3rd, 2016 at $67.24. In approximately 2 months, DexCom has returned 35.31% as of today's recent price of $90.99.
DXCM: 92.09 (+0.38)

After Yesterday's Decline of 1.02%, DexCom Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 10, 2:16PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $89.17 to a high of $90.96. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $90.48 on volume of 442,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DXCM: 92.09 (+0.38)

DexCom Launches New Clinic Portal for the DexCom CLARITY® Diabetes Management Solution
PR Newswire - Mon Aug 08, 7:10AM CDT
DexCom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the availability of enhanced data sharing features for physician and patient users of the DexCom CLARITY® diabetes management solution. The cloud-based solution simplifies CGM data reporting and management, and now facilitates the secure sharing of data between physicians and their patients enabling both to gain quick access to important insights that can be used to assess treatment outcomes. DexCom CLARITY works with the DexCom G5® Mobile Continuous Glucose Monitoring System by automatically sending a patient's CGM data to a secure cloud-based system that can easily be accessed by the patient's health care professional.
DXCM: 92.09 (+0.38)

DexCom (DXCM) Q2 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:18AM CDT
DexCom Inc. (DXCM) reported loss of 24 cents per share in the second quarter of 2016, much wider than the Zacks Consensus Estimate of a loss of 11 cents.
BABY: 40.64 (+0.93), DXCM: 92.09 (+0.38), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)

DexCom, Inc. Reports Second Quarter 2016 Financial Results
BusinessWire - Tue Aug 02, 3:01PM CDT
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2016.
DXCM: 92.09 (+0.38)

Look at Aug 2 Medical Instrument Earnings: IDXX, DXCM, CGNT
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:07AM CDT
Medical, one of the 16 broader Zacks sectors, has so far exhibited a promising performance.
DXCM: 92.09 (+0.38), IDXX: 114.09 (+0.93), CGNT: 1.22 (+0.06)

SmarTrend Watching for Potential Pullback in Shares of DexCom After 1.32% Gain
Comtex SmarTrend(R) - Wed Jun 01, 2:07PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $62.68 to a high of $65.60. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $65.43 on volume of 718,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 92.09 (+0.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 101

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 103

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
Birkenstock’s Athens Stores Put Brand Control to Work

Updated Category News Views 76

A 62-square-meter shop on Ermou Street can say plenty about a brand’s ambitions. Birkenstock is opening its first two Greek stores in Athens, moving beyond its existing wholesale and retail-partner presence with locations it can shape from the floorboards up. The first site at Ermou 18 is stated to have opened on November 12, 2026; the announcement itself is dated...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 99

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 62

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading

Top 5 Most Recently Viewed Articles

Redsun Properties Faces $350 Million Bond Payment Crisis Ahead

Updated Category News Views 189

Redsun Properties Announces Inability to Pay Bond Chinese property developer Redsun Properties has communicated its inability to meet a $350 million bond payment, which is due shortly. This situation has raised considerable concern within the financial markets as it highlights the ongoing issues facing property developers in China. Details of the Bond Issue This bond,...

Continue Reading
Etruscus Resources Unveils Promising Findings at Zappa Target

Updated Category News Views 135

Etruscus Resources Makes Progress at Key Exploration Sites Etruscus Resources Corp. is thrilled to report on the encouraging findings from its exploration program at the Rock & Roll Property. This property is situated in the Golden Triangle region, known for its wealth of mineral resources. The exploration program, which included comprehensive rock sampling and geological...

Continue Reading
MetLife's Strategic Focus: Navigating Q3 2024 Earnings

Updated Category News Views 1091

MetLife Announces Q3 2024 Results and New Frontier Strategy In the third quarter of 2024, MetLife, Inc. (MET) reported adjusted earnings of $1.4 billion, translating to $1.93 per share. This reflects a decline from previous year figures, yet a 12% year-to-date increase in adjusted earnings per share (EPS) excluding notable items. The insurance powerhouse has seen positive...

Continue Reading
VEON Invests in Ukraine: Commitment to Digital Growth

Updated Category News Views 125

VEON's Commitment to Investing in Ukraine VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has recently made significant news with its promise to enhance Ukraine’s telecommunications infrastructure. In collaboration with its fully-owned subsidiary, Kyivstar, VEON participated in the 2024 Yalta European Strategy (YES) Annual Meeting. At this event, the focus...

Continue Reading
Expanding Diabetes Care: From Monitoring to Change

Updated Category News Views 44

Breaking Ground at the AGP & DTx Summit Diabetes management ain't what it used to be, and the 4th AGP & DTx Summit in Shenzhen gave us an eyeful of change. Under the banner "Beyond Glucose," experts from all corners came together to talk shop about Continuous Glucose Monitoring (CGM) and how it might shake up diabetes care. CGM: More Than a Gadget See, CGM's not just a...

Continue Reading